|34.64||+0.36 / +1.05%|
As of 4:04pm ET
|34.64||0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Emergent BioSolutions Inc have a median target of 40.00, with a high estimate of 45.00 and a low estimate of 38.00. The median estimate represents a +15.47% increase from the last price of 34.64.
The current consensus among 3 polled investment analysts is to Buy stock in Emergent BioSolutions Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.